tradingkey.logo
tradingkey.logo
Search

Outlook Therapeutics Says FDA Acknowledged Receipt Of Co's BLA Resubmission - SEC Filing

ReutersApr 8, 2025 9:11 PM
facebooktwitterlinkedin

- Outlook Therapeutics Inc OTLK.O:

  • OUTLOOK THERAPEUTICS INC - FDA ACKNOWLEDGES RECEIPT OF OUTLOOK THERAPEUTICS' BLA RESUBMISSION - SEC FILING

  • OUTLOOK THERAPEUTICS INC - FDA SETS PDUFA GOAL DATE OF AUGUST 27, 2025 - SEC FILING

  • OUTLOOK THERAPEUTICS - FDA DETERMINED CLASS 2 REVIEW FOR OUTLOOK THERAPEUTICS' BLA FOR ONS-5010- SEC FILING

Source text: [ID:n0001558370-25-004606]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI